<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Proper selection of patients at high risk for <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> (SCD) and increasing use of implantable cardioverter-defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) may contribute to improved survival among patients at the highest SCD risk </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: To assess patient survival rate after implantation of an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> without resynchronisation capability in our own patient population </plain></SENT>
<SENT sid="2" pm="."><plain>Using uni- and multivariate analysis, we attempted to identify factors associated with significant worsening of patient survival rate </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: From the population of patients who underwent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation for primary or secondary prevention of SCD in 2008-2010, we selected 376 patients with <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> or <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (56 females, 320 males) </plain></SENT>
<SENT sid="4" pm="."><plain>Mean age was 66.1 ± 11.2 (range 22-89) years </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation protocols and in-hospital and outpatient records were reviewed retrospectively </plain></SENT>
<SENT sid="6" pm="."><plain>We analysed the following clinical and procedural variables: age, gender, left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) functional class, mean heart rate (HR), QRS width, number of antiarrhythmic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions, type of SCD prevention, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> type, performing defibrillation threshold testing (DFT) to establish defibrillation safety margin at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation, ventricular lead location, history of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, medications used (<z:chebi fb="0" ids="2663">amiodarone</z:chebi>, sotalol, beta-blockers, <z:chebi fb="0" ids="35457">angiotensin-converting enzyme inhibitors</z:chebi>/angiotensin receptor blockers, <z:chebi fb="0" ids="35664">statins</z:chebi>, loop <z:chebi fb="40" ids="35498">diuretics</z:chebi>, <z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi>) </plain></SENT>
<SENT sid="7" pm="."><plain>Date and cause of <z:hpo ids='HP_0011420'>death</z:hpo> were established by contacting patient family and/or the hospital to which the patient was admitted shortly before <z:hpo ids='HP_0011420'>death</z:hpo> or the general practitioner caring for the patient (verification of <z:hpo ids='HP_0011420'>death</z:hpo> certificates) </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: During the mean follow-up period of 447 ± 313 days, 46 patients died of known causes </plain></SENT>
<SENT sid="9" pm="."><plain>Causes of <z:hpo ids='HP_0011420'>death</z:hpo> included <z:hpo ids='HP_0001699'>sudden death</z:hpo> in 16 patients, <z:hpo ids='HP_0001635'>heart failure</z:hpo> in 20 patients, and other causes in 10 patients (<z:hpo ids='HP_0002093'>respiratory failure</z:hpo> - 1, <z:hpo ids='HP_0001892'>bleeding diathesis</z:hpo> - 2, <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> - 3, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> - 1, traffic accident - 1, and <z:hpo ids='HP_0001297'>stroke</z:hpo> - 2 patients) </plain></SENT>
<SENT sid="10" pm="."><plain>A comparison between primary and secondary prevention patients was performed </plain></SENT>
<SENT sid="11" pm="."><plain>Mean QRS width &lt;118 ms, resting HR &lt; 78 bpm and LVEF &gt;30% were significant cutoff values for improved survival as determined using the ROC curves </plain></SENT>
<SENT sid="12" pm="."><plain>HR &gt;78 bpm was observed in <z:hpo ids='HP_0000001'>all</z:hpo> SCD patients </plain></SENT>
<SENT sid="13" pm="."><plain>In Kaplan-Meier univariate analysis including 27 parameters potentially influencing survival, 10 significant parameters were identified (type of prevention, presence of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, HR, QRS width, LVEF, NYHA class, performing DFT, and <z:chebi fb="0" ids="35664">statin</z:chebi> and <z:chebi fb="40" ids="35498">diuretic</z:chebi> treatment) </plain></SENT>
<SENT sid="14" pm="."><plain>In Cox multivariate analysis, risk of <z:hpo ids='HP_0011420'>death</z:hpo> was increased with mean LVEV &lt;30% (3-fold increase in risk), no DFT (2-fold increase in risk), NYHA class III or IV (3-fold increase in risk), and no <z:chebi fb="0" ids="35664">statin</z:chebi> use (2-fold increase in risk) </plain></SENT>
<SENT sid="15" pm="."><plain>Mean HR &lt;78 bpm and QRS width &lt;118 ms were independently related to an increased survival </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0011420'>Death</z:hpo> rate was higher in patients with LVEF &lt;30%, NYHA class III or IV, no DFT performed and no <z:chebi fb="0" ids="35664">statin</z:chebi> treatment </plain></SENT>
<SENT sid="17" pm="."><plain>In these patients, indications for cardiac resynchronisation therapy should be considered </plain></SENT>
<SENT sid="18" pm="."><plain>HR &lt;78 bpm and QRS width &lt;118 ms are independent protective factors </plain></SENT>
<SENT sid="19" pm="."><plain>HR &gt;78 bpm was observed in <z:hpo ids='HP_0000001'>all</z:hpo> SCD patients </plain></SENT>
<SENT sid="20" pm="."><plain>Sicker <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients live for a shorter time </plain></SENT>
<SENT sid="21" pm="."><plain>The presence of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, number of antiarrhythmic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> type and revascularisation approach did not affect survival/mortality </plain></SENT>
</text></document>